Coronavirus, stress and panic lower immune defenses
Several studies have proven the existence of a strong correlation between the human psyche and the state of health. In...
Read moreDetails
Coronavirus, the first vial of vaccine is ready: tests on 45 volunteers are underway
The biotech company Moderna has produced the first experimental vaccine against the Coronavirus: tests on 45 volunteers affected by Covid-19...
Read moreDetailsIFIA Academy on the road to progress
The IFIA academy was founded in 2018 aiming to recognize and encourage university inventors, enhance the visibility of academic technology...
Read moreDetailsIFIA: join free to the global online Marketplace for Innovations
FIA. The Global Innovation Exchange is a global online marketplace for innovations, funding, insights, resources, and conversations, allowing the world...
Read moreDetailsCoronavirus: DiaSorin patents test for diagnosis in 60 minutes
The multinational pharmaceutical company DiaSorin is ready to launch a new test that will prove positive for Coronavirus in just...
Read moreDetailsCoronavirus: a drug for rheumatoid arthritis could stop the virus
At Cotugno Hospital in Naples, a team of doctors administered a drug for rheumatoid arthritis to a group of patients...
Read moreDetailsCoronavirus: “We are close to creating a vaccine”
Researchers at the Galilee Research Institute announced that they are close to creating a vaccine for the Coronavirus: "Developed from...
Read moreDetailsIFIA: “The health of inventors is our top priority”
IFIA informs inventors that due to the spread of Coronavirus, we do not recommend participating in any inventions events.
Read moreDetailsCoronavirus: schools closed? Lessons in Augmented Reality are starting
In Italy schools are closed to prevent the spread of Coronavirus: some Institutes have started e-learning programs with real "lessons"...
Read moreDetailsCoronavirus: it’s online the videogame to find the cure
The University of Washington at Seattle has created a video game in which users must create an antiviral protein to...
Read moreDetailsThe Patent ® Newspaper registered at the court of Salerno with n.42019. Editor-in-Chief Giovanni Sapere | Copyright 2019 © Creatiwa Studio S.r.l. Publisher | All rights reserved | For advertising: Creatiwa Studio Sr.l. Head office Via privata del Gonfalone 3, 20123 Milan | Registered office: Via Scavate Casse Rosse snc – 84131 Salerno | Tax code, VAT no. 05675660657 Registration with the Register of Companies of Salerno REA SA – 465001
2017 – 2025 The Patent ™ Director Giovanni Sapere